Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Jesus I. Luna"'
Autor:
Robert J. Canter, Steven K. Grossenbacher, Jennifer A. Foltz, Ian R. Sturgill, Jiwon S. Park, Jesus I. Luna, Michael S. Kent, William T. N. Culp, Mingyi Chen, Jaime F. Modiano, Arta M. Monjazeb, Dean A. Lee, William J. Murphy
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 5, Iss 1, Pp 1-16 (2017)
Abstract Background We have previously shown that radiotherapy (RT) augments natural killer (NK) functions in pre-clinical models of human and mouse cancers, including sarcomas. Since dogs are an excellent outbred model for immunotherapy studies, we
Externí odkaz:
https://doaj.org/article/d9d90a18101e43b28f38e4ccfff5995e
Autor:
William J. Murphy, Robert J. Canter, Jesus I. Luna, Mingyi Chen, Michael S. Kent, Jiwon S. Park, Sita S. Withers, Jaime F. Modiano, Ellen E. Sparger, Robert B. Rebhun, Arta M. Monjazeb
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 4, Iss 1 (2016)
Despite recent major clinical breakthroughs in human cancer immunotherapy including the use of checkpoint inhibitors and engineered T cells, important challenges remain, including determining the sub-populations of patients who will respond and who w
Externí odkaz:
https://doaj.org/article/a6f1431ec5084fa9bcd705c3a6405183
Autor:
Alexander A. Merleev, Mingyi Chen, Ian R. Sturgill, Cordelia Dunai, Catherine T. Le, Lam T. Khuat, Robert J. Canter, Kevin Stoffel, Sarah L. Parker, Dan Knights, Dan L. Longo, Emanual Michael Maverakis, Mehrdad Abedi, Ziming Wang, Armin Rashidi, Jesus I. Luna, Arta M. Monjazeb, Shernan G. Holtan, Robin R. Shields-Cutler, William J. Murphy, Maneesh Dave, James L.M. Ferrara, Helen E. Raybould, Bruce R. Blazar, Shyam K. More, Chien-Chun Steven Pai, John E. Levine
Publikováno v:
Sci Transl Med
The efficacy of allogeneic hematopoietic stem cell transplantation (allo-HSCT) is limited by acute and chronic graft-versus-host disease (GVHD). The impact of obesity on allo-HSCT outcomes is poorly understood. Here, we report that obesity had a nega
Autor:
Thomas S. Griffith, Raid Aljumaily, Christine M. Minnar, Robert B. Rebhun, Ziming Wang, Sami Ibrahimi, Alexander A. Merleev, Karen Kelly, Emanual Michael Maverakis, Steven K. Grossenbacher, Dan L. Longo, Ian R. Sturgill, William J. Murphy, Cordelia Dunai, Catherine T. Le, Dennis J. Hartigan-O'Connor, Lam T. Khuat, Sara K. Vesely, Ethan G. Aguilar, Bruce R. Blazar, Robert J. Canter, Kevin Stoffel, Annie Mirsoian, Sarbajit Mukherjee, Jesus I. Luna, Kurt A. Schalper, Alice F. Tarantal, Arta M. Monjazeb, Roslyn Rivkah Isseroff, Gema Méndez-Lagares, Sita S. Withers, Asim Saha, Michael Machiorlatti
Publikováno v:
Nature Medicine. 25:141-151
The recent successes of immunotherapy have shifted the paradigm in cancer treatment, but because only a percentage of patients are responsive to immunotherapy, it is imperative to identify factors impacting outcome. Obesity is reaching pandemic propo
Publikováno v:
Journal of Biomedical Materials Research Part A. 104:1162-1174
Mesenchymal stem cells (MSCs) are promising for the regeneration of tendon and ligament tissues. Toward realizing this potential, microenvironment conditions are needed for promoting robust lineage-specific differentiation into tenocytes/ligament fib
Autor:
Michiko Shimoda, Guillaume Luxardi, Ruiwu Liu, Alexander A. Merleev, Yoshikazu Takada, Laura P. Olney, Kit S. Lam, Stephanie T. Le, Nathan E. Haigh, Daniel Yoon, Elisa M. Ovadia, Jesus I. Luna, Chen Guo, Emanual Michael Maverakis, Nelvish N. Lal, Roslyn Rivkah Isseroff, Alina I. Marusina, April M. Kloxin, Sucharita Boddu, Jan A. Nolta
Publikováno v:
Stem cells (Dayton, Ohio)REFERENCES. 38(2)
Therapeutic applications for mesenchymal stem/stromal cells (MSCs) are growing; however, the successful implementation of these therapies requires the development of appropriate MSC delivery systems. Hydrogels are ideally suited to cultivate MSCs but
Autor:
Jesus I. Luna, Arta M. Monjazeb, Jennifer A. Foltz, Steven K. Grossenbacher, Robert J. Canter, William T. N. Culp, Dean A. Lee, Ian R. Sturgill, Michael S. Kent, Mingyi Chen, William J. Murphy, Jaime F. Modiano, Jiwon Sarah Park
Publikováno v:
Journal for immunotherapy of cancer, vol 5, iss 1
Journal for Immunotherapy of Cancer
Canter, RJ; Grossenbacher, SK; Foltz, JA; Sturgill, IR; Park, JS; Luna, JI; et al.(2017). Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial. Journal for ImmunoTherapy of Cancer, 5(1). doi: 10.1186/s40425-017-0305-7. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/0hj110cn
Journal for ImmunoTherapy of Cancer, Vol 5, Iss 1, Pp 1-16 (2017)
Journal for Immunotherapy of Cancer
Canter, RJ; Grossenbacher, SK; Foltz, JA; Sturgill, IR; Park, JS; Luna, JI; et al.(2017). Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial. Journal for ImmunoTherapy of Cancer, 5(1). doi: 10.1186/s40425-017-0305-7. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/0hj110cn
Journal for ImmunoTherapy of Cancer, Vol 5, Iss 1, Pp 1-16 (2017)
Background We have previously shown that radiotherapy (RT) augments natural killer (NK) functions in pre-clinical models of human and mouse cancers, including sarcomas. Since dogs are an excellent outbred model for immunotherapy studies, we sought to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8eb8e896b690c95a23a180269378e4ba
https://escholarship.org/uc/item/0hj110cn
https://escholarship.org/uc/item/0hj110cn
Autor:
Alexander A. Merleev, Siba P. Raychaudhuri, Emanual Michael Maverakis, David Fiorentino, Jesus I. Luna, Alina I. Marusina, Anupam Mitra, Smriti Kundu-Raychaudhuri
Publikováno v:
The Journal of Investigative Dermatology
TO THE EDITOR Transforming growth factor-β (TGF-β) and platelet-derived growth factor (PDGF) are central mediators of fibrosis, and their overexpression contributes to the pathophysiology of scleroderma, chiefly by inducing the overproduction of ex
Autor:
Elizabeth A. Wang, Alexander A. Merleev, Emanual Michael Maverakis, Itzel Bustos-Villalobos, Wenchang Guo, Anupam Mitra, Hawa Sultani, Gaurav Bhardwaj, Alina I. Marusina, Jesus I. Luna, Jennifer Williams Bergstrom, Andrea Sukhov, Hsing Jien Kung, Nathan E. Haigh, Ruiwu Liu, Kit S. Lam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1d54b0ef7aa728ee888da79ee96c757
https://europepmc.org/articles/PMC6459605/
https://europepmc.org/articles/PMC6459605/
Publikováno v:
Expert opinion on biological therapy, vol 17, iss 3
Luna, JI; Grossenbacher, SK; Murphy, WJ; & Canter, RJ. (2017). Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy. Expert Opinion on Biological Therapy, 17(3), 313-324. doi: 10.1080/14712598.2017.1271874. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/7bb9k7zj
Luna, JI; Grossenbacher, SK; Murphy, WJ; & Canter, RJ. (2017). Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy. Expert Opinion on Biological Therapy, 17(3), 313-324. doi: 10.1080/14712598.2017.1271874. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/7bb9k7zj
© 2016 Informa UK Limited, trading as Taylor & Francis Group. Introduction: Standard cytoreductive cancer therapy, such as chemotherapy and radiotherapy, are frequently resisted by a small portion of cancer cells with ‘stem-cell’ like properties
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe4d2730c1ecd00314ea14a9d7206226
https://escholarship.org/uc/item/7bb9k7zj
https://escholarship.org/uc/item/7bb9k7zj